Filamentous aggregations of phosphorylated α-synuclein in Schwann cells (Schwann cell cytoplasmic inclusions) in multiple system atrophy - Wikidata - wikimedia - TriplyDB

Filamentous aggregations of phosphorylated α-synuclein in Schwann cells (Schwann cell cytoplasmic inclusions) in multiple system atrophy

Filamentous aggregations of phosphorylated α-synuclein in Schwann cells (Schwann cell cytoplasmic inclusions) in multiple system atrophy

http://www.wikidata.org/entity/Q35627057

about

Molecular Pathological Classification of Neurodegenerative Diseases: Turning towards Precision Medicine Review: Multiple system atrophy: emerging targets for interventional therapies Animal modeling an oligodendrogliopathy--multiple system atrophy Involvement of Peripheral Nerves in the Transgenic PLP-α-Syn Model of Multiple System Atrophy: Extending the Phenotype FTY720/Fingolimod Reduces Synucleinopathy and Improves Gut Motility in A53T Mice: CONTRIBUTIONS OF PRO-BRAIN-DERIVED NEUROTROPHIC FACTOR (PRO-BDNF) AND MATURE BDNF.The Synucleinopathies: Twenty Years On.Review: Spreading the word: precise animal models and validated methods are vital when evaluating prion-like behaviour of alpha-synuclein.ɑ-Synuclein strains and the variable pathologies of synucleinopathies.Multiple system atrophy: pathogenic mechanisms and biomarkers.Accumulation of phosphorylated α-synuclein in subpial and periventricular astrocytes in multiple system atrophy of long duration.Neuropathology of autonomic dysfunction in synucleinopathies.Potential clinical utility of multiple system atrophy biomarkers.Alpha-synuclein levels in patients with multiple system atrophy: a meta-analysis.Multiple System Atrophy: An Oligodendroglioneural Synucleinopathy.α-Synuclein pathology in the cranial and spinal nerves in Lewy body disease.

P2860

Q26768648-4400D2E3-E73F-495F-9B91-4D5758607232 Q26770919-D5FE3163-9C4D-4937-868C-8124960D0994 Q28074659-DD3493C0-CBE6-460C-868E-8C250996379F Q35819324-872E9B63-8EC6-4B54-AD71-029970B2D77B Q37277536-4785AB25-F070-4084-B56E-62EB7FBDF941 Q37693375-461F5EBA-CBE1-4DB9-8388-CCE64A4E3C6F Q38669105-E79D7182-CA96-4149-92C4-CF81A17D9012 Q38753941-121B2BC3-05E4-467A-8860-05E47202C426 Q38813304-484526E1-0EE7-4ABE-8640-7F902199853D Q42481819-A9E8AE74-16D9-4771-8FD6-33F2A2F736A4 Q47649279-6BDA9E25-9126-4C9D-95CA-E2724AB41876 Q47663712-FE0A9F04-6FAC-431B-99BE-0F935B86FB61 Q47754301-AF7B0F1A-9BE5-4FC3-8528-A23990C98396 Q49562668-A5D762D6-3396-443C-B8ED-B4585095B4BC Q52146886-BD7A1D36-FE04-43EB-B01F-C35BC06D4889

P2860

Filamentous aggregations of phosphorylated α-synuclein in Schwann cells (Schwann cell cytoplasmic inclusions) in multiple system atrophy

http://www.wikidata.org/entity/Q35627057

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Filamentous aggregations of ph ...... ns) in multiple system atrophy

@ast

Filamentous aggregations of ph ...... ns) in multiple system atrophy

@en

type

label

Filamentous aggregations of ph ...... ns) in multiple system atrophy

@ast

Filamentous aggregations of ph ...... ns) in multiple system atrophy

@en

prefLabel

Filamentous aggregations of ph ...... ns) in multiple system atrophy

@ast

Filamentous aggregations of ph ...... ns) in multiple system atrophy

@en

P1433

Q35627057-90343FB2-9830-4DCB-9BBB-9578C208DF5B

P1476

Q35627057-681A389C-F675-43F5-ADC9-B7703E293C21

P2093

Q35627057-1D4FC139-CA51-44BE-9E5A-0D78A8C3B0F7

Q35627057-35C0726F-B911-4174-A48C-6F0E2544D790

Q35627057-6A4CB9A3-9802-471E-A904-EBF2891AA26F

Q35627057-752CE96E-08D3-43CA-95FA-B5F995985BFD

Q35627057-75CB3702-146B-4979-B780-055FE40F0253

Q35627057-82DAA6AD-04A1-47B5-8E84-AB428CD2B1FD

Q35627057-87B081F3-1A09-4253-8674-931176484B0C

Q35627057-B5D3E397-EA82-4990-BD21-32D19B883D5F

Q35627057-B79A5884-E20D-40CF-AD57-888F47CE36FA

Q35627057-CAA8D4AD-BE25-4A04-B00E-53AAF5548BE9

P2860

Q35627057-0B94C0A1-E762-432B-AF73-235108E02E63

Q35627057-0F5F1E8D-6D78-43D5-B523-2ED0ADC561CF

Q35627057-12C9D940-ABC9-4098-B35A-16186549B962

Q35627057-1F704F3B-CB54-406F-BF4B-A271BD6E8501

Q35627057-225BD7BB-CBB8-4FEE-8912-195357D52B92

Q35627057-27FA6344-4CFB-4499-B7BB-F333848C9F70

Q35627057-3001078B-0ED1-45C2-88B8-9E5183042970

Q35627057-401443E0-4BEE-4D7B-A524-8E887B6837A1

Q35627057-40D8841C-50E9-4408-84D9-E1C7A822CC56

Q35627057-47228A05-96C2-41A3-9BBC-337B739B1696

P2888

Q35627057-D7C293D0-5C3B-4791-839E-D5C8EAAA41FA

P304

Q35627057-016BFFD7-C6B0-44E1-9889-97330A4FCA13

P31

Q35627057-1E7F86B6-FA8A-497C-9082-A1E47093AA2B

P356

Q35627057-04827A03-EBC6-4CB2-9CA9-A93811219CAE

P478

Q35627057-75CCF4FD-D8C9-4B6D-97EF-08FF85DE22FD

P50

Q35627057-3715A2AC-1EE8-4995-B66F-3A64236AAB5A

P577

Q35627057-0FCE7D48-37E9-4AE4-BACE-5589D366979E

P5875

Q35627057-FE600628-CC39-4774-9E50-2530F79B40C2

P6179

Q35627057-50D1C531-4602-4DEB-B6F5-31238CD9E578

P698

Q35627057-0DF2D99B-D4D8-4CE6-8CFA-D48D2D26E012

P921

Q35627057-7F883E64-B763-4BDD-BFB2-BEFCE969BD60

Q35627057-CCA236F8-7B43-47AD-BBF7-7E4A9658D18A

P932

Q35627057-C32C593C-DC88-4DA2-9006-0CB56B7AACE7

P356

S40478-015-0208-0

P1433

Acta neuropathologica communications

P1476

Filamentous aggregations of ph ...... ns) in multiple system atrophy

@en

P2093

Akiyoshi Kakita

http://www.w3.org/2001/XMLSchema#string

Fumiaki Mori

http://www.w3.org/2001/XMLSchema#string

Hidekachi Kurotaki

http://www.w3.org/2001/XMLSchema#string

Hitoshi Takahashi

http://www.w3.org/2001/XMLSchema#string

Keiko Nakamura

http://www.w3.org/2001/XMLSchema#string

Koichi Wakabayashi

http://www.w3.org/2001/XMLSchema#string

Kunikazu Tanji

http://www.w3.org/2001/XMLSchema#string

Masahiko Tomiyama

http://www.w3.org/2001/XMLSchema#string

Masahito Yamada

http://www.w3.org/2001/XMLSchema#string

Yasuko Toyoshima

http://www.w3.org/2001/XMLSchema#string

P2860

Second consensus statement on the diagnosis of multiple system atrophy

GDNF: a potent survival factor for motoneurons present in peripheral nerve and muscle

Alpha-synuclein immunoreactivity in normal and neoplastic Schwann cells

Metabolic regulator LKB1 is crucial for Schwann cell-mediated axon maintenance.

Neurodegeneration in a transgenic mouse model of multiple system atrophy is associated with altered expression of oligodendroglial-derived neurotrophic factors.

alpha-Synuclein is phosphorylated in synucleinopathy lesions.

Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome).

Neuron-to-neuron transmission of α-synuclein fibrils through axonal transport

Bladder dysfunction in a transgenic mouse model of multiple system atrophy.

Multiple system atrophy: a primary oligodendrogliopathy.

P2888

s40478-015-0208-0

P304

29

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S40478-015-0208-0

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-05-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

277028575

http://www.w3.org/2001/XMLSchema#string

P6179

1033514841

http://www.w3.org/2001/XMLSchema#string

P698

25990096

http://www.w3.org/2001/XMLSchema#string

P921

phosphorylation

P932

4438578

http://www.w3.org/2001/XMLSchema#string